Do you know anyone suffering from eczema??
If so, we have a new clinical trial that is actively recruiting patients. Please call 855-554-6374 or use this link to notify us that you would like to be contacted.
Clinical Trial Government Identifier NCT05158023.
Note: Qualified study participants will receive study drug, related testing, and compensation for their time and travel.
ASLAN004-003: A randomized, double-blind, placebo-controlled, multicenter, dose-ranging trial to evaluate the efficacy and safety of ASLAN004 in adult patients with moderate-to-severe atopic dermatitis. The study length is 16-weeks.
This study is looking to recruit adult patients (age > 18 years), with moderate-to-severe eczema for at least 6 months. The minimum of involved Body Surface Area is 10%.